$1.09
-0.04-3.54%
Pre-Market: Mar 18, 7:43 PM EDT
Comments
Loading...
CytoSorbents Earnings Estimates, EPS & Revenue | NASDAQ:CTSO | Benzinga
CytoSorbents reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 25
EPS Estimate
$-0.070
Quarterly Revenue Estimate
$9.43M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$33.79M
Analyze the earnings history of CytoSorbents using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CTSO | CytoSorbents | -$0.12 | -$0.06 | — | — | $9.79M | $9.70M | — | — | 05/08/2025 | Get Alert |
| CTSO | CytoSorbents | -$0.12 | -$0.07 | — | — | $8.70M | $9.43M | — | — | 03/25/2025 | Get Alert |
| CTSO | CytoSorbents | -$0.21 | -$0.06 | -$0.04 | 33.33% | $8.81M | $10.18M | $9.39M | -7.76% | 11/07/2024 | Get Alert |
| CTSO | CytoSorbents | -$0.14 | -$0.09 | -$0.08 | 11.11% | $9.42M | $9.73M | $9.89M | 1.70% | 08/13/2024 | Get Alert |
| CTSO | CytoSorbents | -$0.17 | -$0.12 | -$0.12 | 0.00% | $9.45M | $9.78M | $9.79M | 0.07% | 05/09/2024 | Get Alert |
| CTSO | CytoSorbents | -$0.01 | -$0.14 | -$0.12 | 14.29% | $9.39M | $9.28M | $8.70M | -6.25% | 03/14/2024 | Get Alert |
| CTSO | CytoSorbents | -$0.28 | -$0.12 | -$0.21 | -75.00% | $8.11M | $9.49M | $8.81M | -7.15% | 11/09/2023 | Get Alert |
| CTSO | CytoSorbents | -$0.25 | -$0.11 | -$0.14 | -27.27% | $8.50M | $11.03M | $9.42M | -14.59% | 08/01/2023 | Get Alert |
| CTSO | CytoSorbents | -$0.21 | -$0.13 | -$0.17 | -30.77% | $8.69M | $8.73M | $9.45M | 8.24% | 05/02/2023 | Get Alert |
| CTSO | CytoSorbents | -$0.21 | -$0.17 | -$0.01 | 94.12% | $10.78M | $8.72M | $9.39M | 7.69% | 03/09/2023 | Get Alert |
| CTSO | CytoSorbents | -$0.15 | -$0.16 | -$0.28 | -75.00% | $9.76M | $8.98M | $8.11M | -9.68% | 11/03/2022 | Get Alert |
| CTSO | CytoSorbents | -$0.11 | -$0.13 | -$0.25 | -92.31% | $12.02M | $9.58M | $8.50M | -11.32% | 08/02/2022 | Get Alert |
| CTSO | CytoSorbents | -$0.10 | -$0.12 | -$0.21 | -75.00% | $10.60M | $9.73M | $8.69M | -10.67% | 05/03/2022 | Get Alert |
| CTSO | CytoSorbents | -$0.01 | -$0.13 | -$0.21 | -61.54% | $11.96M | $10.11M | $10.78M | 6.65% | 03/08/2022 | Get Alert |
| CTSO | CytoSorbents | -$0.02 | -$0.12 | -$0.15 | -25.00% | $10.55M | $11.02M | $9.76M | -11.43% | 11/04/2021 | Get Alert |
| CTSO | CytoSorbents | -$0.08 | -$0.04 | -$0.11 | -175.00% | $9.79M | $12.27M | $12.02M | -2.00% | 08/03/2021 | Get Alert |
| CTSO | CytoSorbents | -$0.10 | -$0.03 | -$0.10 | -233.33% | $8.71M | $11.50M | $10.60M | -7.83% | 05/04/2021 | Get Alert |
| CTSO | CytoSorbents | -$0.12 | -$0.04 | -$0.01 | 75.00% | $7.43M | $10.95M | $11.96M | 9.19% | 03/09/2021 | Get Alert |
| CTSO | CytoSorbents | -$0.21 | -$0.09 | -$0.02 | 77.78% | $6.09M | $9.51M | $10.55M | 10.90% | 11/04/2020 | Get Alert |
| CTSO | CytoSorbents | -$0.11 | -$0.08 | -$0.08 | 0.00% | $6.23M | $9.66M | $9.79M | 1.40% | 08/04/2020 | Get Alert |
| CTSO | CytoSorbents | -$0.15 | -$0.13 | -$0.10 | 23.08% | $5.19M | $7.00M | $8.71M | 24.39% | 05/05/2020 | Get Alert |
CytoSorbents (CTSO) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-07 | $-0.04 | $-0.06 | 33.3 % |
| Q2 | 2024-08-13 | $-0.08 | $-0.09 | 11.1 % |
| Q1 | 2024-05-09 | $-0.12 | $-0.12 | 0.00 % |
| Q4 | 2024-03-14 | $-0.12 | $-0.14 | 14.3 % |
CytoSorbents (CTSO) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-07 | $9.39M | $10.18M | -7.76 % |
| Q2 | 2024-08-13 | $9.90M | $9.73M | 1.70 % |
| Q1 | 2024-05-09 | $9.79M | $9.78M | 0.07 % |
| Q4 | 2024-03-14 | $8.70M | $9.28M | -6.25 % |
FAQ
When is CytoSorbents (NASDAQ:CTSO) reporting earnings?
CytoSorbents (CTSO) is scheduled to report earnings on May 8, 2025. The last reported earnings were for reported on November 7, 2024 for Q3.
What were the latest earnings per share (EPS) for CytoSorbents (NASDAQ:CTSO)?
The Actual EPS was $-0.04, which beat the estimate of $-0.06.
What were CytoSorbents’s (NASDAQ:CTSO) revenues?
The Actual Revenue was $9.4M, which missed the estimate of $10.2M.
Browse earnings estimates, EPS, and revenue on all stocks.